T1	Organism 88 100	C57BL/6 mice
T2	OriginSiteDisease 214 260	model of chronic obstructive pulmonary disease
T3	Organism 262 274	C57BL/6 mice
T4	SampleTreatment 350 389	prototype modified risk tobacco product
T5	SampleTreatment 391 396	pMRTP
*	Equiv T4 T5
T6	SampleTreatment 586 605	reference cigarette
T7	SampleTreatment 607 611	3R4F
*	Equiv T6 T7
T8	SampleTreatment 624 637	pMRTP aerosol
T9	SampleTreatment 699 717	switching-to-pMRTP
T10	SampleTreatment 777 784	control
T11	SampleTreatment 786 803	fresh air-exposed
*	Equiv T10 T11
T12	SampleTreatment 858 876	switching to pMRTP
*	Equiv T9 T12
T13	Sex 2361 2367	Female
T14	Treatment 2431 2435	Sham
T15	Treatment 2437 2473	exposed to filtered, conditioned air
*	Equiv T14 T15
T16	FactorValue 2431 2435	Sham
T17	Treatment 2479 2483	3R4F
T18	FactorValue 2595 2600	pMRTP
T19	FactorValue 2729 2738	Cessation
T20	FactorValue 2835 2850	Switch to pMRTP
T21	FactorValue 2479 2483	3R4F
T22	Treatment 2595 2600	pMRTP
T23	Treatment 2729 2738	Cessation
T24	Treatment 2835 2850	Switch to pMRTP
T25	Treatment 2485 2533	exposed to mainstream smoke from 3R4F cigarettes
*	Equiv T17 T25
T26	Treatment 2602 2637	exposed to a MRTP prototype aerosol
*	Equiv T22 T26
T27	Treatment 2740 2825	exposed to 3R4F for 2 months and then to filtered, conditioned air for up to 5 months
*	Equiv T23 T27
T28	Treatment 2852 2925	exposed to 3R4F for 2 months and then to pMRTP aerosol for up to 5 months
*	Equiv T24 T28
T29	OrganismPart 3678 3699	bronchoalveolar fluid
T30	OrganismPart 56129 56140	right lungs
T31	BiologicalReplicate 56160 56163	six
T32	BiologicalReplicate 56144 56147	six
T33	Organism 56148 56152	mice
T34	Time 56269 56270	1
T35	Time 56272 56273	3
T36	Time 56275 56276	5
T37	Time 56282 56283	7
T38	Time 56324 56325	3
T39	Time 56327 56328	5
T40	Time 56334 56335	7
T41	FactorValue 56288 56292	3R4F
T42	FactorValue 56297 56302	pMRTP
T43	FactorValue 56340 56349	cessation
T44	FactorValue 56354 56360	switch
T45	OrganismPart 56245 56256	Lung tissue
T46	OrganismPart 56416 56447	inferior lobe of the right lung
*	Equiv T30 T45 T46
T47	FractionationMethod 56696 56751	two-dimensional (2D)-polyacrylamide gel electrophoresis
T48	FractionationMethod 56753 56757	PAGE
*	Equiv T47 T48
T49	Label 56787 56839	isobaric tags for relative and absolute quantitation
T50	Label 56841 56846	iTRAQ
*	Equiv T49 T50
T51	Staining 58284 58294	SYPRO Ruby
T52	SampleTreatment 58632 58647	in-gel digested
T53	CleavageAgent 58662 58699	Trypsin Gold, Mass Spectrometry Grade
T54	IonizationType 58854 58897	matrix-assisted laser desorption/ionization
T55	Instrument 58931 58962	(UltraFleXtrem MALDI-TOF/TOF-MS
T56	Label 59612 59624	iTRAQ 8-plex
T57	CleavageAgent 59712 59719	Trypsin
T58	FactorValue 59941 59986	mix containing 50 mug of all protein extracts
T59	Time 59992 60007	each time point
T60	Label 60067 60084	iTRAQ channel 114
T61	Label 60124 60129	iTRAQ
T62	PooledSample 60139 60145	pooled
T63	FractionationMethod 60642 60669	EASY-nanoLC 1000 instrument
T64	Instrument 60692 60702	Q Exactive
T65	FractionationMethod 60770 60797	50 cm C18RP RSLC EASY-spray
T66	TechnicalReplicate 61020 61025	twice
